VAV3 and prostate carcinoma: However, further work is required to elucidate the functional difference between nuclear and cytoplasmic VAV3, which is reminiscent of the results for PAK1[49] and could be linked to the activation of the androgen receptor, as previously shown in prostate cancer[46,62].